Close
Close

Rigel Pharmaceuticals - Immune Thrombocytopenic Purpura

Partner

Not provided

Rare Disease

Immune Thrombocytopenic Purpura

Sponsor

Rigel Pharmaceuticals

Access Program Information

C-935788-055 is an open-label, multi-center, expanded access (EAP) study.

Contact

Contact: Sandra Tong, M.D. (650-624-1100)

Locations

Free Newsletter